| Financial Year |
March 31 2023 |
| Monetary Funds |
561,942,126.35 |
| Held-for-trading Financial Assets |
254,247,815.43 |
| Notes Receivable |
13,757,722.02 |
| Accounts Receivable |
215,338,583.46 |
| Advances to Suppliers |
91,891,026.09 |
| Other Receivables |
130,680,202.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
10,765,118.75 |
| Dividend Receivable |
-- |
| Inventories |
332,813,414.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
352,787,925.58 |
| Other Current Assets |
14,380,869.69 |
| Total Current Assets |
2,761,478,830.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,533,042.68 |
| Long-term Equity Investment |
138,209,900.06 |
| Investment Properties |
10,983,185.35 |
| Fixed Assetes |
1,454,032,573.16 |
| Under-construction Projects |
179,333,921.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
251,611,509.45 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
36,320,784.24 |
| Deferred Income Tax Assets |
88,880,345.50 |
| Other Non-Current Assets |
558,475,730.40 |
| Sub-Total of Non-Current Assets |
2,761,365,200.56 |
| Total Assets |
5,522,844,031.43 |
| Short-Term Loans |
556,854,964.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
414,269,599.93 |
| Accounts Payable |
379,494,604.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
56,159,742.72 |
| Taxes Payable |
37,376,674.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
605,421,548.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,298,340.50 |
| Other Current Liabilities |
57,183,012.19 |
| Sub-Total of Current Liabilities |
2,474,047,903.54 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,180,683.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
120,060,654.81 |
| Total Liabilities |
2,594,108,558.35 |
| Paid-In Capital(Or Share Stock) |
311,819,895.00 |
| Capital Surplus |
765,624,494.01 |
| Surplus Reserve |
120,446,402.84 |
| LESS:Treasury Stock |
88,144,194.70 |
| Undistributed Profits |
1,824,848,955.10 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,928,735,473.08 |
| Owner's Equity（Stockholder's Equity） |
2,928,735,473.08 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,522,844,031.43 |
